22h
Zacks Investment Research on MSNIs Trending Stock Pfizer Inc. (PFE) a Buy Now?Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...
Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...
Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...
Market indexes have been falling as investors are beginning to assume President Trump will make good on repeated promises to ...
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...
With its stock down 5.4% over the past month, it is easy to disregard Pfizer (NYSE:PFE). We, however decided to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results